Cargando…

B cells and multiple sclerosis spinal cord pathology

Detalles Bibliográficos
Autores principales:	Schmierer, Klaus, Baker, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018026/ https://www.ncbi.nlm.nih.gov/pubmed/32285483 http://dx.doi.org/10.1111/bpa.12840

Ejemplares similares

Honing in on magnetic resonance imaging predictors of multiple sclerosis pathology
por: Schmierer, Klaus
Publicado: (2023)

Axonal loss in the multiple sclerosis spinal cord revisited
por: Petrova, Natalia, et al.
Publicado: (2017)

High‐resolution quantitative MRI of multiple sclerosis spinal cord lesions
por: McDowell, Amy R., et al.
Publicado: (2022)

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
por: Baker, David, et al.
Publicado: (2017)

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
por: Mao, Zhifeng, et al.
Publicado: (2018)

B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis
por: Reali, Camilla, et al.
Publicado: (2020)

Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
por: Ceronie, Bryan, et al.
Publicado: (2018)

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis
por: Andelova, Michaela, et al.
Publicado: (2019)

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
por: Baker, David, et al.
Publicado: (2022)

Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?
por: Grussu, Francesco, et al.
Publicado: (2017)

Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology()
por: Petzold, Axel, et al.
Publicado: (2008)

The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
por: Baker, David, et al.
Publicado: (2020)

Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology
por: Calabresi, Peter A., et al.
Publicado: (2010)

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis
por: Afolabi, Dayo, et al.
Publicado: (2017)

Harnessing Spinal Interneurons for Spinal Cord Repair
por: Zholudeva, Lyandysha V, et al.
Publicado: (2022)

Advances in spinal cord imaging in multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2019)

The fate of proliferating cells in the injured adult spinal cord
por: McTigue, Dana M, et al.
Publicado: (2011)

On a Case of Disseminated Sclerosis of the Brain and Spinal Cord (Multiple Sclerosis)
por: Coats, Joseph
Publicado: (1879)

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis
por: Alvarez‐Gonzalez, Cesar, et al.
Publicado: (2017)

Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
por: Breakell, Thomas, et al.
Publicado: (2020)

Cell Therapy in Spinal Cord Injury: a Mini- Reivew
por: Mehrabi, Soraya, et al.
Publicado: (2013)

Quantitative spinal cord MRI and sexual dysfunction in multiple sclerosis
por: Seyman, Estelle, et al.
Publicado: (2022)

The Emerging Role of Biological Sex in Cell Therapy for Spinal Cord Injury
por: Tucker, Ashley, et al.
Publicado: (2023)

Imaging of the Spinal Cord in Multiple Sclerosis: Past, Present, Future
por: Chen, Yongsheng, et al.
Publicado: (2020)

Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19
por: Shin, Robert K., et al.
Publicado: (2022)

PATHOLOGY OF THE SPINAL CORD
Publicado: (1978)

Dendritic Spines in the Spinal Cord: Live Action Pain
por: Benson, Curtis A, et al.
Publicado: (2020)

Commentary: The aggregation of marginal gains for spinal cord protection
por: Chatterjee, Subhasis, et al.
Publicado: (2020)

No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
por: Pakpoor, Julia, et al.
Publicado: (2015)

On Sclerosis of the Spinal Cord: Including Locomotor Ataxy, Spastic Spinal Paralysis, and Other System-Diseases of the Spinal Cord: Their Pathology, Symptoms, Diagnosis, and Treatment
Publicado: (1885)

On Sclerosis of the Spinal Cord: Including Locomotor Ataxia, Spastic Spinal Paralysis and Other System-Diseases of the Spinal Cord, Their Pathology, Symptoms, Diagnosis and Treatment
Publicado: (1885)

Lateral Sclerosis of the Spinal Cord
por: Shaw, J. E.
Publicado: (1884)

The Reality of Benefit in Surgical Removal for Spinal Cord Cavernous Malformation: Commentary on “Acceptance of Early Surgery for Treatment of Spinal Cord Cavernous Malformation in Contemporary Japan”
por: Takahashi, Toshiyuki, et al.
Publicado: (2023)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

A Risk Score for Predicting Multiple Sclerosis
por: Dobson, Ruth, et al.
Publicado: (2016)

Regeneration of Corticospinal Axons into Neural Progenitor Cell Grafts After Spinal Cord Injury
por: Poplawski, Gunnar HD, et al.
Publicado: (2020)

Commentary on “Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury”
por: Luo, Jeffrey, et al.
Publicado: (2023)

The State of Play with iPSCs and Spinal Cord Injury Models
por: Hodgetts, Stuart I., et al.
Publicado: (2015)

Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity
por: Freund, Patrick, et al.
Publicado: (2010)

Preparing individuals with spinal cord injury for extreme storms in the era of climate change
por: Shapiro, Lauren T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0f8vmcsm3jqu95oigrqdvp2a8f